Maintenance of low disease activity and remission with etanercept–disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial

BACKGROUND: Current guidelines on the treatment of rheumatoid arthritis (RA) recommend early therapy targeting the achievement of low disease activity (LDA) or clinical remission. Little published information is available on the success of this treatment strategy in Latin America. In a subset analys...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Zerbini, Cristiano A.F., Abud-Mendoza, Carlos, Mendez-Patarroyo, Paul, De Angelo Andrade, Mauricio, Pedersen, Ron, Vlahos, Bonnie, Borlenghi, Cecilia Elena
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6133462/
https://ncbi.nlm.nih.gov/pubmed/30200078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011989
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados